SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio,” or the “Company”), a clinical-stage biotechnology company developing ...
SAN MATEO, Calif. and CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced ...
BOSTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) is pleased to announce the election of 11 new board directors and several new section governing board chairs and vice chairs at ...
Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity (PIPE) ...
As an advisor to boards and a former executive recruiter, I’ve read thousands of bios and résumés over my career. OK, if I'm being really honest, I've skimmed thousands of bios and résumés over my ...
SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a clinical stage, next-generation precision oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) is pleased to announce the election of H. Thomas Watkins, President & CEO of Human Genome Sciences, Inc, as its new Chairman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results